Multiplex Assay Kit for Tumor Necrosis Factor Receptor 1 (TNFR1) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD120A; P55; TNFRSF1A; TBP1; FPF; TNF-R; TNF-R-I; TNF-R55; TNFAR; TNFR55; TNFR60; P55-R; P60; Tumor necrosis factor receptor 1; Tumor necrosis factor-binding protein 1

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Tumor Necrosis Factor Receptor 1 (TNFR1) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Tumor Necrosis Factor Receptor 1 (TNFR1) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Tumor Necrosis Factor Receptor 1 (TNFR1) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Tumor Necrosis Factor Receptor 1 (TNFR1) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 93-103 99
EDTA plasma(n=5) 95-104 98
heparin plasma(n=5) 80-103 86

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Tumor Necrosis Factor Receptor 1 (TNFR1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Tumor Necrosis Factor Receptor 1 (TNFR1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Tumor Necrosis Factor Receptor 1 (TNFR1) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 84-92% 81-90% 78-91% 85-98%
EDTA plasma(n=5) 85-96% 87-94% 87-102% 80-91%
heparin plasma(n=5) 97-105% 85-102% 79-91% 95-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:TNFR1) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
PLoS ONE A Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of Herniated Intervertebral Discs: Identification of Potential Target Proteins for Gene Therapeutic Approaches Plosone: Source
Mediators of Inflammation High Glucose Level Disturbs the Resveratrol-Evoked Curtailment of CX3CL1/CX3CR1 Signaling in Human Placental Circulation pubmed:28655972
Annals of Neurology  High complement levels in astrocyte‐derived exosomes of Alzheimer disease Pubmed:29406582
International Journal of Immunopathology and Pharmacology VEGF-R2 and TNF-R1 expression and cytokine production by samples of mammary adenocarcinomas and correlations with histopathological parameters of these … Pubmed:29985074
Cell Death & Disease Inhibition of transmembrane TNF-α shedding by a specific antibody protects against septic shock Pubmed: 31383857
Journal of Cardiovascular Translational Research XPO1 Gene Therapy Attenuates Cardiac Dysfunction in Rats with Chronic Induced Myocardial Infarction Pubmed: 31768947
Frontiers in Pharmacology M10, a Myricetin-3-ObD-Lactose Sodium Salt, Prevents Ulcerative Colitis Through Inhibiting Necroptosis in Mice Pubmed: 33041798
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPB499Ra01 Recombinant Tumor Necrosis Factor Receptor 1 (TNFR1) Positive Control; Immunogen; SDS-PAGE; WB.
RPB499Ra02 Recombinant Tumor Necrosis Factor Receptor 1 (TNFR1) Positive Control; Immunogen; SDS-PAGE; WB.
PAB499Ra02 Polyclonal Antibody to Tumor Necrosis Factor Receptor 1 (TNFR1) WB; IHC; ICC; IP.
PAB499Ra01 Polyclonal Antibody to Tumor Necrosis Factor Receptor 1 (TNFR1) WB; IHC; ICC; IP.
LAB499Ra71 Biotin-Linked Polyclonal Antibody to Tumor Necrosis Factor Receptor 1 (TNFR1) WB; IHC; ICC.
SEB499Ra ELISA Kit for Tumor Necrosis Factor Receptor 1 (TNFR1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB499Ra Multiplex Assay Kit for Tumor Necrosis Factor Receptor 1 (TNFR1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.